Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels: A Multicenter Study (CREATE)-Reference-Cited by-同舟云学术

Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels: A Multicenter Study (CREATE)

Published:2020-12 Issue: Volume: Page:
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Sonneveld Milan J.,Park Jun Yong,Kaewdech Apichat,Seto Wai-Kay,Tanaka Yasuhito,Carey Ivana,Papatheodoridi Margarita,van Bömmel Florian,Berg Thomas,Zoulim Fabien,Ahn Sang Hoon,Dalekos George N.,Erler Nicole S.,Höner zu Siederdissen Christoph,Wedemeyer Heiner,Cornberg Markus,Yuen Man-Fung,Agarwal Kosh,Boonstra Andre,Buti Maria,Piratvisuth Teerha,Papatheodoridis George,Maasoumy Benjamin

Funder

Fujirebio Europe

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference22 articles.

1. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study;Marcellin;Lancet,2013

2. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection;J Hepatol,2017

3. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance;Terrault;Hepatology,2018

4. Systematic review: cessation of long-term nucluos(t)ide analogue therapy in patients with hepatitis B e antigen-negative chronic hepatitis B;Chang;Aliment Pharmacol Ther,2015

5. Discontinuation of oral antivirals in chronic hepatitis B: a systematic review;Papatheodoridis;Hepatology,2016

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Higher hepatitis B core-specific T cell response is associated with a lower risk of clinical relapse after discontinuation of oral antiviral treatment;Journal of Microbiology, Immunology and Infection;2024-08

2. Predictors of hepatic flares after nucleos(t)ide analogue cessation - Results of a global cohort study (RETRACT-B study);Journal of Hepatology;2024-08

3. High end‐of‐treatment hepatitis B core‐related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapy;Liver International;2024-07-15

4. Detection technology and clinical applications of serum viral products of hepatitis B virus infection;Frontiers in Cellular and Infection Microbiology;2024-07-05

5. PegIFN alpha-2a reduces relapse in HBeAg-negative patients after nucleo(s)tide analogue cessation: A randomized-controlled trial;Journal of Hepatology;2024-07